4. 4 "sideløbende anvendelse anbefales ikke" i stedet for som en kontraindikation.
Therefore, the CHMP recommends that, according to the above mentioned guideline, this aspect should be mentioned in section 4.5 of the SPC with cross reference to section 4.4 “ concomitant use not recommended” rather than a contra-indication.